These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Induction of cytotoxic capacity by recombinant gamma interferon in human myelomonocytic leukaemia cell lines.
    Author: Kuosmanen M, Sarelin H, Andersson LC.
    Journal: Scand J Immunol; 1987 Mar; 25(3):219-23. PubMed ID: 3105044.
    Abstract:
    We have investigated the ability of human recombinant gamma interferon (IFN-gamma) to induce functional differentiation in three human myelomonocytic cell lines U937, RC2A, and ML-2. Treatment with IFN-gamma induced natural killer (NK) cell like cytotoxicity against K-562 cells in ML-2 and RC2A but not in U937. U937 and RC2A displayed a spontaneous antibody-dependent cell-mediated cytotoxicity (ADCC), which against nucleated target cells was significantly increased in U937 but not in RC2A after treatment with IFN-gamma. ML-2 did not display ADCC against nucleated targets either before or after IFN-gamma treatment, but lysed efficiently antibody-coated erythrocytes. All three cell lines displayed enhanced ADCC against erythrocytes after IFN-gamma treatment. Spontaneous phagocytosis of erythrocytes was seen in U937, and this was enhanced by IFN-gamma treatment, while ML-2 and RC2A were phagocytically inactive before and after treatment with IFN-gamma. The differentiated functions induced by IFN-gamma treatment in this panel of phenotypically closely related cell lines offers an interesting model for further studies on the IFN-gamma regulated gene expression. Moreover, the increased cytolytic capacity after exposure to IFN-gamma might have implications on the use of IFN-gamma for treatment of myelomonocytic malignancies. In such cases, IFN-gamma might even increase the aggressiveness of the tumour.
    [Abstract] [Full Text] [Related] [New Search]